Viltolarsen
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
The Utilization, Reimbursement, and Cost of Targeted Therapies for Duchenne Muscular Dystrophy (DMD) in US Medicaid Programs: A Descriptive Trend Analysis from 2017 to 2022.
Journal: Pharmaceutical medicine
Published: September 09, 2025
Evolution and Breakthroughs in Exon Skipping and Splice Modulation: From Inception to Clinical Success.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Exon-Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis.
Journal: Journal of comparative effectiveness research
Published: July 18, 2025
Antisense oligonucleotide as novel therapies for neurogenetic disorders
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: January 08, 2025
Givinostat (Duvyzat) for Duchenne muscular dystrophy.
Journal: The Medical letter on drugs and therapeutics
Published: January 06, 2025
Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 04, 2025
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.
Journal: Advances in therapy
Published: August 28, 2024
Correction to: Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy.
Journal: Advances in therapy
Published: August 02, 2024
Last Updated: 02/24/2026